Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| brain | 19 studies | 45% ± 14% | |
| lung | 13 studies | 31% ± 13% | |
| kidney | 6 studies | 30% ± 12% | |
| intestine | 6 studies | 25% ± 10% | |
| heart | 6 studies | 49% ± 15% | |
| eye | 5 studies | 31% ± 14% | |
| breast | 4 studies | 37% ± 10% | |
| liver | 3 studies | 27% ± 13% | |
| uterus | 3 studies | 32% ± 9% | |
| adipose | 3 studies | 39% ± 19% | |
| skin | 3 studies | 29% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 8077.89 | 244 / 245 | 100% | 42.18 | 502 / 502 |
| brain | 100% | 3933.54 | 2630 / 2642 | 100% | 56.61 | 703 / 705 |
| esophagus | 100% | 4494.69 | 1442 / 1445 | 98% | 32.66 | 179 / 183 |
| ovary | 100% | 5086.95 | 180 / 180 | 97% | 27.17 | 418 / 430 |
| thymus | 100% | 7105.12 | 653 / 653 | 96% | 25.12 | 580 / 605 |
| kidney | 99% | 3462.52 | 88 / 89 | 96% | 30.87 | 865 / 901 |
| pancreas | 100% | 3285.78 | 328 / 328 | 89% | 14.91 | 158 / 178 |
| lung | 100% | 6088.10 | 577 / 578 | 89% | 20.29 | 1025 / 1155 |
| breast | 100% | 11543.54 | 459 / 459 | 87% | 32.49 | 975 / 1118 |
| stomach | 100% | 4185.29 | 359 / 359 | 86% | 18.12 | 245 / 286 |
| intestine | 100% | 5398.89 | 966 / 966 | 84% | 12.65 | 441 / 527 |
| liver | 99% | 2887.52 | 223 / 226 | 77% | 11.00 | 314 / 406 |
| uterus | 100% | 5893.38 | 170 / 170 | 72% | 16.10 | 332 / 459 |
| bladder | 100% | 6638.00 | 21 / 21 | 63% | 9.64 | 320 / 504 |
| skin | 93% | 5795.48 | 1680 / 1809 | 52% | 6.45 | 245 / 472 |
| adrenal gland | 100% | 3169.40 | 257 / 258 | 37% | 3.98 | 86 / 230 |
| adipose | 100% | 10530.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7645.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 6033.17 | 860 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 2953.81 | 797 / 803 | 0% | 0 | 0 / 0 |
| spleen | 99% | 2670.67 | 238 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 17.17 | 33 / 45 |
| eye | 0% | 0 | 0 / 0 | 16% | 1.45 | 13 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.46 | 2 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0031099 | Biological process | regeneration |
| GO_0021846 | Biological process | cell proliferation in forebrain |
| GO_0061141 | Biological process | lung ciliated cell differentiation |
| GO_0060510 | Biological process | type II pneumocyte differentiation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0009617 | Biological process | response to bacterium |
| GO_0010001 | Biological process | glial cell differentiation |
| GO_1902894 | Biological process | negative regulation of miRNA transcription |
| GO_0002062 | Biological process | chondrocyte differentiation |
| GO_0048665 | Biological process | neuron fate specification |
| GO_0060041 | Biological process | retina development in camera-type eye |
| GO_0072089 | Biological process | stem cell proliferation |
| GO_0006260 | Biological process | DNA replication |
| GO_2000647 | Biological process | negative regulation of stem cell proliferation |
| GO_0060509 | Biological process | type I pneumocyte differentiation |
| GO_0071679 | Biological process | commissural neuron axon guidance |
| GO_0060486 | Biological process | club cell differentiation |
| GO_0021960 | Biological process | anterior commissure morphogenesis |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0010458 | Biological process | exit from mitosis |
| GO_0002067 | Biological process | glandular epithelial cell differentiation |
| GO_0019827 | Biological process | stem cell population maintenance |
| GO_0021740 | Biological process | principal sensory nucleus of trigeminal nerve development |
| GO_0007420 | Biological process | brain development |
| GO_0030902 | Biological process | hindbrain development |
| GO_0021780 | Biological process | glial cell fate specification |
| GO_0010467 | Biological process | gene expression |
| GO_0001894 | Biological process | tissue homeostasis |
| GO_2000795 | Biological process | negative regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO_0060689 | Biological process | cell differentiation involved in salivary gland development |
| GO_2000791 | Biological process | negative regulation of mesenchymal cell proliferation involved in lung development |
| GO_0009611 | Biological process | response to wounding |
| GO_0060662 | Biological process | salivary gland cavitation |
| GO_0014009 | Biological process | glial cell proliferation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0001650 | Cellular component | fibrillar center |
| GO_0044300 | Cellular component | cerebellar mossy fiber |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NFIB |
| Protein name | Nuclear factor 1 B-type (CCAAT-box-binding transcription factor) (Nuclear factor I/B) (TGGCA-binding protein) Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein) Nuclear factor I B Nuclear factor 1 |
| Synonyms | hCG_1742080 |
| Description | FUNCTION: Transcriptional activator of GFAP, essential for proper brain development . Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . |
| Accessions | A0A1B0GU97 ENST00000397579.6 A0A1B0GTC1 Q5VW31 O00712 ENST00000637640.1 A0A2R8Y7V8 U3KQE8 ENST00000380921.3 U3KPY9 Q5VW28 A0A1B0GW37 ENST00000636063.1 A0A1B0GWB8 ENST00000637742.1 ENST00000397575.7 A0A0A0MRX8 ENST00000636432.1 A0A1B0GWI9 ENST00000380934.8 ENST00000646622.1 ENST00000493697.1 Q5VW30 ENST00000380953.6 [O00712-5] ENST00000543693.5 [O00712-6] ENST00000636735.1 A0A1B0GWJ4 Q5VW27 ENST00000380959.7 [O00712-1] A0A0S2Z4H3 Q5VW26 ENST00000380924.1 ENST00000606230.2 A0A1B0GVN4 ENST00000636057.1 ENST00000397581.7 Q5W0Y9 ENST00000635877.1 |
